Note: NQF 0047 is not included in the current measure set used for reporting in 2014. > NQF 0047 specifies that RXCUI 745679 is acceptable for the numerator criteria. This identifies "200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler" - got this from RxNav - http://rxnav.nlm.nih.gov/REST/rxcui/745679 . I thought this measure was checking for asthma controller meds, so is this just a bad code?   Response: Thank you for the comment. This has been corrected in the Value Set Authority Center for Meaningful Use Stage 2.   > I've also noticed that there are a number of RXCUI values related to those provided in the specifications that would probably qualify. Using 745679 as an example you can see that several other RXCUI's represent the specific brand versions of albuterol ( http://rxnav.nlm.nih.gov/REST/rxcui/745679/related?rela=has_tradename ). Is that an acceptable way to find additional RXCUI's that should count towards a measure, or should we just use the set provided by the specifications.   Response: We are investigating exactly what level of RxNorm codes should be included in all value sets. In the meantime, mapping to brand versions is acceptable.   > Lastly, a lot of our customers only have NDC codes, so in order to calculate their measures we map from the RXCUI values in the specifications to NDC values (again using the RxNav API ie. http://rxnav.nlm.nih.gov/REST/rxcui/745679/ndcs) . Is this an acceptable way of calculating the measure, or should we require that our customers store RxNorm codes? We don't necessarily have full control over that as we are a 3rd party data warehouse and reporting solution.   Response: Mapping NDC to RxNorm is an acceptable way to report the measure.